1. Dose-adjusted EPOCH-R (etoposide, prednisone, vincristine, cyclophosphamide, doxorubicin, and rituximab) in untreated aggressive diffuse large B-cell lymphoma with MYC rearrangement: a prospective, multicentre, single-arm phase 2 study. Issue 12 (December 2018) Authors: Dunleavy, Kieron; Fanale, Michelle A; Abramson, Jeremy S; Noy, Ariela; Caimi, Paolo Fabrizio; Pittaluga, Stefania; Parekh, Samir; Lacasce, Ann; Hayslip, John W; Jagadeesh, Deepa; Nagpal, Sunil; Lechowicz, Mary Jo; Gaur, Rakesh; Lucas, Andrea; Melani, Christopher; Roschewski, Mark; Steinberg, Seth... Journal: Lancet Issue: Volume 5:Issue 12(2018) Page Start: e609 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗